1. Can we improve the definition of high‐risk, hormone naïve, non‐metastatic prostate cancer?. (February 2014) Authors: Tombal, Bertrand; Alcaraz, Antonio; James, Nicholas; Valdagni, Riccardo; Irani, Jacques Journal: BJU international Issue: Volume 113(2014)Supplement 2 Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Can we improve the definition of high‐risk, hormone naïve, non‐metastatic prostate cancer?. (February 2014) Authors: Tombal, Bertrand; Alcaraz, Antonio; James, Nicholas; Valdagni, Riccardo; Irani, Jacques Journal: BJU international Issue: Volume 113:Number 2(2014:Feb.) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature. (April 2017) Authors: Gravis, Gwenaëlle; Audenet, François; Irani, Jacques; Timsit, Marc-Olivier; Barthelemy, Philippe; Beuzeboc, Philippe; Fléchon, Aude; Linassier, Claude; Oudard, Stéphane; Rebillard, Xavier; Richaud, Pierre; Rouprêt, Morgan; Thiery Vuillemin, Antoine; Vincendeau, Sébastien; Albiges, Laurence; Rozet... Journal: Cancer treatment reviews Issue: Volume 55(2017) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer. Issue 1 (23rd May 2013) Authors: Jardel, Pauline; Debiais, Celine; Godet, Julie; Irani, Jacques; Fromont, Gaelle Journal: Histopathology Issue: Volume 63:Issue 1(2013) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and tolerance of one‐third full dose bacillus Calmette–Guérin maintenance therapy every 3 months or 6 months: Two‐year results of URO‐BCG‐4 multicenter study. (25th September 2014) Authors: Pfister, Christian; Kerkeni, Walid; Rigaud, Jerome; Le Gal, Sophie; Saint, Fabien; Colombel, Marc; Guy, Laurent; Wallerand, Herve; Irani, Jacques; Soulie, Michel; The Cancer Committee of the French Urological Association Journal: International journal of urology Issue: Volume 22:Number 1(2015) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy. (1st January 2021) Authors: Doisy, Laure; Cimier, Arnaud; Adypagavane, Aurélien; Walz, Jochen; Marquette, Thibault; Maubon, Thomas; Rybikowski, Stanislas; Fakhfakh, Sami; Loverde, Kevin; Mottet, Nicolas; Irani, Jacques; Lechevallier, Eric; Rossi, Dominique; Gravis, Gwenaelle; Pignot, Géraldine Journal: International journal of hyperthermia Issue: Volume 38:Number 1(2021) Page Start: 1633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ERG expression in prostate cancer: The prognostic paradox. Issue 15 (29th August 2014) Authors: Taris, Michael; Irani, Jacques; Blanchet, Pascal; Multigner, Luc; Cathelineau, Xavier; Fromont, Gaelle Journal: Prostate Issue: Volume 74:Issue 15(2014) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer. Issue 3 (March 2017) Authors: Nouhaud, François X.; Rigaud, Jérome; Saint, Fabien; Colombel, Marc; Irani, Jacques; Soulie, Michel; Pfister, Christian Journal: Anti-cancer drugs Issue: Volume 28:Issue 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Is intermittent androgen‐deprivation therapy beneficial for patients with advanced prostate cancer?. (16th April 2014) Authors: Wolff, Johannes M.; Abrahamsson, Per‐Anders; Irani, Jacques; Calais da Silva, Fernando Journal: BJU international Issue: Volume 114:Number 4(2014:Oct.) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Temporary contraindication of obese recipients in kidney transplantation: A new morphometric tool for decision support. Issue 4 (18th March 2020) Authors: Pinar, Ugo; Renard, Yohann; Bedretdinova, Dina; Parier, Bastien; Hammoudi, Yacine; Irani, Jacques; Bessede, Thomas Journal: Clinical transplantation Issue: Volume 34:Issue 4(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗